These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38478363)

  • 41. [Use of midazolam for refractory status epilepticus in children].
    Lampin ME; Dorkenoo A; Lamblin MD; Botte A; Leclerc F; Auvin S
    Rev Neurol (Paris); 2010; 166(6-7):648-52. PubMed ID: 20171707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of Ketamine in Barbiturate Coma for Status Epilepticus.
    McGinn KA; Bishop L; Sarwal A
    Clin Neuropharmacol; 2016; 39(1):62-5. PubMed ID: 26757317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children].
    Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS
    Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136
    [No Abstract]   [Full Text] [Related]  

  • 44. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
    Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E
    CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential consequences of high-dose infusion of ketamine for refractory status epilepticus: case reports and systematic literature review.
    Golub D; Yanai A; Darzi K; Papadopoulos J; Kaufman B
    Anaesth Intensive Care; 2018 Sep; 46(5):516-528. PubMed ID: 30189827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital.
    Tasker RC; Goodkin HP; Sánchez Fernández I; Chapman KE; Abend NS; Arya R; Brenton JN; Carpenter JL; Gaillard WD; Glauser TA; Goldstein J; Helseth AR; Jackson MC; Kapur K; Mikati MA; Peariso K; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Pediatr Crit Care Med; 2016 Oct; 17(10):968-975. PubMed ID: 27500721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Comparative Study of Midazolam and Target-Controlled Propofol Infusion in the Treatment of Refractory Status Epilepticus.
    Masapu D; Gopala Krishna KN; Sanjib S; Chakrabarti D; Mundlamuri RC; Manohar N; Mariamma P; Satishchandra P; Umamaheswara Rao GS
    Indian J Crit Care Med; 2018 Jun; 22(6):441-448. PubMed ID: 29962746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Propofol versus thiopental sodium for the treatment of refractory status epilepticus.
    Prabhakar H; Bindra A; Singh GP; Kalaivani M
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009202. PubMed ID: 22895985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early Combination Therapy of Ketamine and Midazolam in Patients with Refractory Status Epilepticus in Hemodynamic Unstable State.
    Choi JW; Shin JW
    J Epilepsy Res; 2021 Dec; 11(2):150-153. PubMed ID: 35087725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres.
    García-Ruiz M; Rodríguez PM; Palliotti L; Lastras C; Romeral-Jiménez M; Morales IG; Rey CP; Rodrigo-Gisbert M; Campos-Fernández D; Santamarina E; Carbonell BP
    Seizure; 2024 Apr; 117():13-19. PubMed ID: 38301485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Status Epilepticus: An Update on Pharmacological Management.
    Almohaish S; Tesoro EP; Brophy GM
    Semin Neurol; 2024 Jun; 44(3):324-332. PubMed ID: 38580318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
    Rossetti AO; Logroscino G; Bromfield EB
    Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of status epilepticus: a survey of neurologists.
    Claassen J; Hirsch LJ; Mayer SA
    J Neurol Sci; 2003 Jul; 211(1-2):37-41. PubMed ID: 12767495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
    Niquet J; Baldwin R; Norman K; Suchomelova L; Lumley L; Wasterlain CG
    Epilepsia; 2016 Sep; 57(9):1406-15. PubMed ID: 27500978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Refractory generalised convulsive status epilepticus : a guide to treatment.
    Kälviäinen R; Eriksson K; Parviainen I
    CNS Drugs; 2005; 19(9):759-68. PubMed ID: 16142991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [S2k guidelines: status epilepticus in adulthood : Guidelines of the German Society for Neurology].
    Rosenow F; Weber J; ;
    Nervenarzt; 2021 Oct; 92(10):1002-1030. PubMed ID: 33751150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Refractory status epilepticus.
    Murthy JM
    Neurol India; 2006 Dec; 54(4):354-8. PubMed ID: 17114841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.